← Back to Search

Robotic Surgery

Robot-Assisted Surgery for Surgical Procedures

Phase 2
Recruiting
Led By Mehdi Moslemi-Kebria
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days of operation
Awards & highlights

Study Summary

This trial tested a robotic device that may allow for less invasive surgeries, reducing pain, complications, and speeding recovery.

Who is the study for?
This trial is for adults over 18 who are scheduled for robot-assisted abdominal or pelvic surgery and have consented to participate. It's not suitable for individuals with a BMI over 45, those who've had unsuccessful minimally invasive surgeries before, or have conditions that make such surgeries risky like severe lung disorders.Check my eligibility
What is being tested?
The study is testing the da Vinci SP1098 robotic device in performing less invasive abdominal and pelvic surgeries through a single small incision. The goal is to see if it leads to less pain, fewer complications, and faster recovery compared to traditional methods.See study design
What are the potential side effects?
While specific side effects aren't listed, typical risks of robot-assisted surgery may include infection at the incision site, bleeding, potential injury to surrounding organs or tissues during operation, and reactions related to anesthesia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days of operation
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days of operation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Conversion of operation to laparotomy
Incidence of major surgical complications

Trial Design

1Treatment groups
Experimental Treatment
Group I: Device feasibility (da Vinci SP1098 robotic system)Experimental Treatment1 Intervention
Patients undergo surgery using the da Vinci SP1098 robotic system on study.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Minimally invasive surgical treatments, such as those performed with the da Vinci SP1098 robotic device, work by allowing surgeons to conduct complex procedures through a single, small incision. This approach reduces physical trauma, leading to less pain, fewer complications, and faster recovery times. For patients, this means a quicker return to normal activities, reduced hospital stays, and an overall improvement in postoperative quality of life.
How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature.Posterior tibial nerve stimulation and faecal incontinence: a review.

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
570 Previous Clinical Trials
1,922,507 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,281 Total Patients Enrolled
Mehdi Moslemi-KebriaPrincipal InvestigatorCity of Hope Comprehensive Cancer Center

Media Library

da Vinci Single Port Robotic System (Robotic Surgery) Clinical Trial Eligibility Overview. Trial Name: NCT05672368 — Phase 2
Illness Research Study Groups: Device feasibility (da Vinci SP1098 robotic system)
Illness Clinical Trial 2023: da Vinci Single Port Robotic System Highlights & Side Effects. Trial Name: NCT05672368 — Phase 2
da Vinci Single Port Robotic System (Robotic Surgery) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05672368 — Phase 2
~22 spots leftby Jan 2025